The purpose of this study is to find out if reSET, an FDA authorized mobile therapeutic, is effective in treating stimulant use disorder and helping keep HIV viral load suppression stable among men who have sex with men who are living with HIV and have a stimulant use disorder.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
500
Participants in this group will use a mobile application that delivers treatment for substance use disorder. 31 required and 30 optional modules. Among many topics covered in the modules, some are substance use management, communication, emotion management, relationship skills, HIV/Sexually Transmitted Infections and triggers for risky sex. In the reSET app you will get the chance to earn rewards for two activities: (1) completing a module and (2) providing a negative urine drug screen in exchange for a motivational or monetary prize. You will have 12 weeks to complete as many modules as you like, about 4 modules per week. Each module takes approximately 10-15 min. Every 3-4 days you will meet with the same study team member to provide a urine drug screen from a place comfortable for you (e.g. home) which will be observed and read via Zoom.
Participants in this group will receive assistance connecting to an in person community-based outpatient treatment program.
University of Miami
Miami, Florida, United States
RECRUITINGChange in days of stimulant use as measured by Timeline FollowBack
Number of days of stimulant use as measured by the Timeline FollowBack using the formula: Daily opioid use- the proportion of days of use
Time frame: 3, 9 and 15 months.
Proportion of subjects with viral suppression
Changes in RNA viral load. Viral suppression (cv\<200copies/ml)
Time frame: 3, 9 and 15 months.
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.